Food Allergy — ED Discharge and Prevention

Key Points

• Epinephrine is the first-line treatment for food-induced anaphylaxis.
• Discharge timing should be individualized according to severity, treatment response, recurrence risk, and access to care.
• Patients should leave with epinephrine access and hands-on device education.
• Antihistamines treat skin symptoms but do not prevent airway compromise or shock.
• Routine corticosteroids are not proven to prevent biphasic anaphylaxis.
• A written action plan should explain when to use epinephrine and when a repeat dose is needed.
• Broad food panels can create false diagnoses and unnecessary dietary restriction.
• Allergy follow-up is needed to confirm the trigger and refine long-term avoidance and treatment.

Algorithm

1. Treat acute anaphylaxis with IM epinephrine and standard airway, breathing, and circulation support.
2. Reassess after each epinephrine dose and repeat when severe symptoms persist.
3. Identify reaction severity and factors that increase recurrence or biphasic risk.
4. Observe until clinically stable for an interval appropriate to the individual risk profile.
5. Before discharge, provide epinephrine devices and verify patient or caregiver technique.
6. Give a written anaphylaxis action plan and food-avoidance instructions.
7. Arrange allergy referral for targeted testing and diagnostic confirmation.
8. Document the suspected trigger, reaction features, treatment, and discharge plan clearly.

Clinical Synopsis & Reasoning

Food-induced anaphylaxis is a rapid systemic hypersensitivity reaction in which airway, breathing, or circulatory compromise can occur with or without prominent skin findings. The emergency diagnosis is clinical. Typical presentations combine urticaria or angioedema with wheeze, throat tightness, hypotension, repetitive vomiting, or other multisystem symptoms after likely food exposure. Isolated mild hives are not automatically anaphylaxis, but waiting for hypotension before treating a rapidly evolving multisystem reaction is dangerous.

Before discharge, confirm that the patient has recovered from the acute event and identify factors that increase concern for recurrent or biphasic symptoms. These include severe initial anaphylaxis, delayed epinephrine, need for multiple epinephrine doses, hypotension, significant respiratory compromise, uncertain trigger, ongoing allergen absorption, difficult access to emergency care, or comorbid disease that would make recurrence dangerous. Observation duration should therefore be individualized rather than fixed to a single universal number of hours.

The discharge diagnosis should name the suspected food when reasonably known while acknowledging uncertainty. A positive food-specific IgE test by itself does not prove that a food caused the event, and broad panel testing in the ED can create false labels. Allergy follow-up is important for targeted skin testing, serum-specific IgE, component testing when useful, and supervised oral food challenge when diagnosis remains uncertain.

The most important discharge safety tool is epinephrine. Patients and caregivers need more than a prescription: they must know where the device is, how to remove its safety mechanism, where to inject it, when to use it, and why they should not wait for an antihistamine to work first. The emergency plan should account for school, work, travel, restaurants, and caregivers when relevant.

Treatment Strategy & Disposition

Acute anaphylaxis is treated with intramuscular epinephrine in the anterolateral thigh and repeated dosing when symptoms persist. Oxygen, airway support, IV fluids for hypotension, and inhaled bronchodilator therapy for ongoing bronchospasm are adjuncts. H1 antihistamines can improve itching and urticaria after the patient is stabilized but do not treat laryngeal edema, bronchospasm, or shock. Routine systemic corticosteroids should not be presented as a proven way to prevent biphasic anaphylaxis.

Once symptoms have resolved and observation is appropriate for the reaction severity, prepare the patient for recurrence. Provide epinephrine autoinjectors or an equivalent approved delivery system whenever feasible. The number of devices should be individualized, but access to more than one dose is important for patients who may need repeat epinephrine, have a history of severe reactions, or may be far from emergency care. Demonstrate use with a trainer and have the patient or caregiver perform a return demonstration.

Provide a written anaphylaxis action plan. The plan should say that epinephrine is used first for anaphylaxis, that a second dose may be required if severe symptoms persist, and that emergency medical assistance should be activated based on the clinical situation and local emergency guidance. Patients should understand that antihistamines are for skin symptoms and are not a reason to delay epinephrine.

Counsel on strict avoidance of the suspected food until allergy evaluation clarifies the diagnosis. Teach label reading, cross-contact awareness, restaurant communication, and age-appropriate school or workplace planning. Do not recommend avoidance of multiple unrelated foods simply because screening tests are positive. Dietary restriction should be as specific as possible to preserve nutrition and quality of life.

Refer to an allergist after anaphylaxis. The specialist can confirm the trigger, assess cofactor effects such as exercise or NSAIDs, determine whether an oral food challenge is appropriate, and discuss emerging options such as oral immunotherapy or biologic-assisted strategies for selected patients. Patients with unexplained or recurrent severe anaphylaxis may also need baseline tryptase and assessment for mast-cell disorders.

Epidemiology / Risk Factors

• Food is a leading trigger of anaphylaxis in children and an important trigger in adults.
• Peanut, tree nuts, milk, egg, wheat, soy, fish, shellfish, and sesame account for many clinically significant food allergies.
• Reaction severity is difficult to predict solely from previous episodes or IgE level.
• Delayed epinephrine is associated with worse anaphylaxis outcomes.
• Biphasic reactions are uncommon overall but occur more often after severe initial reactions and repeated epinephrine requirements.

Investigations

Key Discharge Elements

Pharmacology

Prognosis / Complications

• Most food-anaphylaxis episodes resolve completely with timely epinephrine and supportive care.
• Future reaction severity remains unpredictable, so prior mild reactions do not eliminate the need for emergency preparedness.
• Some childhood food allergies resolve over time, while peanut, tree-nut, fish, and shellfish allergy often persist.
• Accurate diagnosis can prevent both dangerous accidental exposure and unnecessary dietary restriction.
• Long-term outcomes improve when patients reliably carry epinephrine and have a clear action plan.

Patient Education / Counseling

• Carry epinephrine where it can be reached immediately, not in a distant car, locker, or checked bag.
• Use epinephrine promptly for anaphylaxis rather than waiting for diphenhydramine or another antihistamine.
• Review food labels every time because ingredients and manufacturing practices can change.
• Tell restaurant staff clearly about the allergy and ask about cross-contact.
• Ensure schools, caregivers, workplaces, and travel companions understand the emergency plan when relevant.
• Keep allergy follow-up even if the trigger seems obvious because diagnostic confirmation affects long-term restrictions.

Notes

The discharge prescription is only useful if the patient can obtain the device and knows how to use it. Cost, pharmacy availability, school access, language, health literacy, and expiration dates are practical parts of anaphylaxis prevention.

Food allergy management should be precise. The goal is not to make the diet as restrictive as possible. It is to identify the clinically relevant trigger, prevent exposure to that trigger, and preserve safe foods whenever possible.

References

1. AAAAI Joint Task Force Anaphylaxis Practice Parameter Resources — Link
2. AAAAI Food Allergy Practice Parameter — Link